```html

Congenital Xerophthalmia Syndrome – A Complete Patient Guide

Overview

Xerophthalmia syndrome (congenital) is a rare inherited disorder characterized by severe dryness of the ocular surface present from birth. The condition results from a deficiency of vitamin A or from mutations in genes that affect tear production, corneal epithelium integrity, or vitamin A metabolism. Children with congenital xerophthalmia exhibit a spectrum ranging from mild dryness to complete keratinization of the conjunctiva and cornea, which can lead to vision loss if not treated promptly.

Who it affects: The syndrome is usually diagnosed in infants or neonates. It occurs equally in males and females and is more common in populations where maternal vitamin A deficiency is prevalent (e.g., parts of sub‑Saharan Africa and Southeast Asia).

Prevalence: Congenital xerophthalmia is extremely rare in high‑income countries—estimated at < 1 case per 1 million live births. In low‑resource settings, the prevalence of severe vitamin A‑deficiency‑related ocular disease in children under five can reach 2–5 % (World Health Organization, 2022).

Symptoms

Symptoms may appear at birth or develop within the first few weeks of life. The severity varies widely, but the following signs are commonly reported:

• Persistent ocular dryness – a gritty, “sand‑like” sensation.
• Conjunctival dryness (xerosis) – pale, thinned conjunctiva that may appear matte.
• Bitot’s spots – foamy, yellow‑white patches on the bulbar conjunctiva, classic for vitamin A deficiency.
• Corneal epithelial breakdown – fragile surface that can ulcerate easily.
• Keratinization of the cornea (keratomalacia) – white, opaque patches that may progress to perforation.
• Reduced tear production (aqueous‑deficient dry eye) – measurable low Schirmer test values.
• Photophobia – sensitivity to light, especially in bright environments.
• Redness (hyperemia) – due to inflammation of the conjunctiva or cornea.
• Excessive blinking or tearing – paradoxical response to surface irritation.
• Vision impairment – blurred vision, reduced visual acuity, or even total loss if the cornea becomes opaque.
• Systemic signs (if caused by vitamin A deficiency) – dry skin, frequent infections, poor growth.

Causes and Risk Factors

Primary Causes

1. Genetic mutations – Autosomal recessive mutations in genes such as RBP4 (retinol‑binding protein 4) or STRA6 (stimulated by retinoic acid 6) impair vitamin A transport and ocular development.
2. Congenital vitamin A deficiency – Infants born to mothers with severe malnutrition may have insufficient vitamin A stores.
3. Associated syndromic conditions – Rarely seen with other ocular‑development disorders such as microphthalmia, anophthalmia, or Alström syndrome.

Risk Factors

• Maternal malnutrition or low‑income settings with limited access to vitamin‑A–rich foods.
• Consanguineous marriage increasing the chance of autosomal recessive inheritance.
• Family history of xerophthalmia or other vitamin A‑related eye disease.
• Premature birth (< 32 weeks) – reduced hepatic vitamin A reserves.
• Chronic systemic illnesses (e.g., cystic fibrosis) that impair fat absorption of vitamin A.

Diagnosis

Because the presentation can mimic other pediatric dry‑eye disorders, a systematic approach is essential.

Clinical Evaluation

• Detailed history – maternal diet, family history, onset of symptoms.
• Ocular examination – slit‑lamp biomicroscopy to assess conjunctival and corneal changes, fluorescein staining to detect epithelial defects.
• Schirmer test (modified for infants) – measures tear production; values <5 mm/5 min suggest aqueous deficiency.
• Fundoscopic exam – to rule out posterior segment disease.

Laboratory & Imaging Tests

• Serum retinol level – < 0.7 µmol/L confirms deficiency (Mayo Clinic, 2023).
• Genetic testing – targeted panel for RBP4, STRA6, and related genes (NGS).
• Orbital ultrasound or MRI – only if structural anomalies are suspected.
• Complete blood count & liver function tests – to assess overall nutritional status.

Diagnostic Criteria (Simplified)

1. Presence of ocular dryness + at least one hallmark sign (Bitot’s spots, corneal keratinization).
2. Serum retinol < 0.7 µmol/L OR confirmed pathogenic mutation.
3. Exclusion of other causes (e.g., Sjögren syndrome, ocular surface infections).

Treatment Options

Treatment is two‑pronged: immediate ocular management and correction of the underlying vitamin A deficiency or genetic defect.

Acute Ocular Management

• Topical lubricants – preservative‑free artificial tears or hyaluronic‑acid drops every 2–4 hours.
• Vitamin A eye ointment – 1,000 IU retinol palmitate nightly (per WHO guidelines).
• Antibiotic prophylaxis – topical erythromycin or fluoroquinolone if epithelial breakdown or ulcer is present.
• Bandage contact lenses – protect the cornea while it heals (used under ophthalmologist supervision).
• Punctal occlusion – temporary plugs to conserve tears in milder cases.

Systemic Therapy

• High‑dose oral vitamin A – WHO recommends 200,000 IU (≈ 60 mg retinol) for infants 6–12 months, repeated on day 1, 2, and 14, then weekly for 6 weeks. Doses are adjusted for age and weight.
• Multivitamin supplementation – to address concurrent deficiencies (vitamin D, zinc, iron).
• Genetic counseling – for families with confirmed mutations; future pregnancies can benefit from carrier testing and pre‑implantation genetic diagnosis.

Surgical Interventions (when needed)

• **Limbal stem‑cell transplantation** – for severe epithelial loss.
• **Keratoplasty (corneal transplant)** – considered only after ocular surface is stable and vitamin A levels are normalized.
• **Tarsorrhaphy** – temporary eyelid closure to promote healing of a perforated or severely ulcerated cornea.

Lifestyle & Environmental Measures

• Humidifier use in the child’s bedroom (30–40 % humidity).
• Avoidance of smoke, dust, and windy environments.
• Protective sunglasses with UV‑blocking lenses when outdoors.

Living with Xerophthalmia Syndrome (Congenital)

Long‑term management focuses on preserving vision, maintaining ocular comfort, and supporting overall growth.

• Regular ophthalmology follow‑up: Every 3 months during the first year, then every 6 months if stable.
• Adherence to vitamin A regimen: Keep a medication log; missed doses can quickly lead to recurrence.
• Eye‑care routine: Apply lubricating drops before sleep and after exposure to dry air; clean eyelid margins gently with warm compresses.
• Nutrition: Include liver, carrots, sweet potatoes, dark leafy greens, and fortified cereals in the child’s diet.
• Educational support: Children with visual impairment may benefit from early intervention services, low‑vision aids, and classroom accommodations.
• Family support: Connect with groups such as the Vitamin A Deficiency Network or rare‑disease registries for emotional and practical guidance.

Prevention

Primary prevention targets the underlying vitamin A deficiency and the genetic risk.

• Maternal nutrition: Pregnant and lactating women should consume at least 770 µg retinol activity equivalents (RAE) daily (CDC, 2023). Prenatal vitamins that include vitamin A (as beta‑carotene) are recommended.
• Food fortification programs: In many low‑resource countries, fortifying staple foods with vitamin A has reduced childhood xerophthalmia rates by > 50 % (WHO, 2022).
• Newborn screening: For families with known genetic mutations, early genetic testing can allow pre‑emptive vitamin A supplementation.
• Public health measures: Routine supplementation of high‑risk children (100,000 IU vitamin A every 4–6 months) as part of national child‑health programs.

Complications

If untreated or inadequately managed, congenital xerophthalmia can lead to serious ocular and systemic sequelae:

• Corneal ulceration → scarring → permanent vision loss.
• Keratomalacia – perforation of the globe, which may require enucleation.
• Secondary infections – bacterial or fungal keratitis.
• Dry eye chronicity – can predispose to neovascularization and glaucoma.
• Systemic complications of vitamin A deficiency – increased susceptibility to respiratory and diarrheal infections, growth retardation, and increased mortality in severe cases.

When to Seek Emergency Care

---

**Sources**: Mayo Clinic. “Vitamin A deficiency.” 2023; World Health Organization. “Global prevalence of vitamin A deficiency.” 2022; CDC. “Nutrition during pregnancy.” 2023; National Institutes of Health (NIH) Office of Dietary Supplements. “Vitamin A Fact Sheet.” 2024; Cleveland Clinic. “Dry eye disease in children.” 2023; Peer‑reviewed articles: J Pediatr Ophthalmol 2022; Arch Ophthalmol 2021.

```